HomeComparePOLXF vs MRK

POLXF vs MRK: Dividend Comparison 2026

POLXF yields 100.70% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 POLXF wins by $3.95M in total portfolio value
10 years
POLXF
POLXF
● Live price
100.70%
Share price
$1.99
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.01M
Annual income
$1,357,581.74
Full POLXF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — POLXF vs MRK

📍 POLXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPOLXFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, POLXF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
POLXF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

POLXF
Annual income on $10K today (after 15% tax)
$8,559.92/yr
After 10yr DRIP, annual income (after tax)
$1,153,944.48/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, POLXF beats the other by $1,145,616.07/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of POLXF + MRK for your $10,000?

POLXF: 50%MRK: 50%
100% MRK50/50100% POLXF
Portfolio after 10yr
$2.03M
Annual income
$683,689.94/yr
Blended yield
33.63%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

POLXF
No analyst data
Altman Z
-3.9
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

POLXF buys
0
MRK buys
0
No recent congressional trades found for POLXF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPOLXFMRK
Forward yield100.70%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$4.01M$56.8K
Annual income after 10y$1,357,581.74$9,798.13
Total dividends collected$3.58M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: POLXF vs MRK ($10,000, DRIP)

YearPOLXF PortfolioPOLXF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$20,770$10,070.49$11,206$366.19+$9.6KPOLXF
2$41,773$19,548.52$12,650$502.35+$29.1KPOLXF
3$81,440$36,743.31$14,407$694.19+$67.0KPOLXF
4$154,089$66,948.23$16,585$967.82+$137.5KPOLXF
5$283,258$118,382.76$19,342$1,363.89+$263.9KPOLXF
6$506,470$203,383.03$22,913$1,947.19+$483.6KPOLXF
7$881,783$339,861.07$27,662$2,823.89+$854.1KPOLXF
8$1,496,510$553,001.45$34,159$4,173.35+$1.46MPOLXF
9$2,478,388$877,122.18$43,337$6,308.80+$2.44MPOLXF
10$4,009,457$1,357,581.74$56,776$9,798.13+$3.95MPOLXF

POLXF vs MRK: Complete Analysis 2026

POLXFStock

Polydex Pharmaceuticals Limited, through its subsidiaries, develops, manufactures, and markets biotechnology-based products for the human pharmaceutical market worldwide. The company also manufactures bulk pharmaceutical intermediates for the veterinary pharmaceutical industry. It primarily offers dextran and derivative products, including iron dextran, a derivative of dextran that is injected into pigs at birth as a treatment for anemia; and dextran sulphate, a specialty chemical derivative of dextran used in biotechnology applications and the pharmaceutical industry. In addition, the company develops Ushercell, a high molecular weight cellulose sulphate for topical vaginal use primarily in the prevention and transmission of AIDS and other sexually transmitted diseases, as well as unplanned pregnancies. Further, it supplies ferric hydroxide and hydrogenated dextran solutions. The company sells its products through independent distributors and wholesalers, as well as directly to companies. The company was formerly known as Polydex Chemicals Limited and changed its name to Polydex Pharmaceuticals Limited in March 1984. Polydex Pharmaceuticals Limited was incorporated in 1979 and is based in Toronto, Canada.

Full POLXF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this POLXF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

POLXF vs SCHDPOLXF vs JEPIPOLXF vs OPOLXF vs KOPOLXF vs MAINPOLXF vs JNJPOLXF vs ABBVPOLXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.